×
About 10,370 results

ALLMedicine™ Lung Transplantation Center

Research & Reviews  3,815 results

Prognostic value of brain natriuretic peptides in patients with pulmonary arterial hype...
https://doi.org/10.1016/j.ahj.2022.05.006
American Heart Journal; Hendriks PM, van de Groep LD et. al.

May 10th, 2022 - Multiple biomarkers have been investigated in the risk stratification of patients with pulmonary arterial hypertension (PAH). This systematic review and meta-analysis is the first to investigate the prognostic value of (NT-pro)BNP in patients with...

Commentary: Challenging the final frontier of lung transplantation.
https://doi.org/10.1016/j.jtcvs.2022.04.003
The Journal of Thoracic and Cardiovascular Surgery; Thomas PA

May 9th, 2022 - Commentary: Challenging the final frontier of lung transplantation.|2022|Thomas PA,|

Pediatric Organ Procurement Surgery
https://emedicine.medscape.com/article/1012328-print

May 9th, 2022 - Organ procurement is intimately tied to the history of organ transplantation and organ donation. To best understand the organ procurement process, reviewing the history of transplantation is helpful. Notable events have included the following: 190...

Pediatric Organ Procurement Surgery
http://emedicine.medscape.com/article/1012328-overview

May 9th, 2022 - Overview Organ procurement is intimately tied to the history of organ transplantation and organ donation. To best understand the organ procurement process, reviewing the history of transplantation is helpful. Notable events have included the follo...

Lung Function Monitoring After Lung Transplantation and Allogeneic Hematopoietic Stem C...
https://doi.org/10.1016/j.clinthera.2022.03.011
Clinical Therapeutics; Sheshadri A, Sacks NC et. al.

May 7th, 2022 - Bronchiolitis obliterans syndrome (BOS) is a major cause of morbidity and mortality in lung transplantation and allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Clinical guidelines recommend lung function monitoring to ai...

see more →

Guidelines  14 results

ISHLT position paper on thoracic organ transplantation in controlled donation after cir...
https://doi.org/10.1016/j.healun.2022.03.005
The Journal of Heart and Lung Transplantation : the Offic... Holm AM, Courtwright A et. al.

Apr 5th, 2022 - Controlled organ donation after circulatory determination of death is increasingly being used for the donation of organs also in thoracic transplantation. This document outlines the position of the International Society for Heart and Lung Transpla...

International consensus recommendations for anesthetic and intensive care management of...
https://doi.org/10.1016/j.healun.2021.07.012
The Journal of Heart and Lung Transplantation : the Offic... Marczin N, de Waal EEC et. al.

Nov 5th, 2021 - International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document.|2021|Marczin N,de Waal EEC,Hopkins PMA,Mulligan MS,Simon A,|

Can Organs from SARS-CoV-2–Positive Donors Be Safely Transplanted?
https://www.jwatch.org/na54012/2021/09/07/can-organs-sars-cov-2-positive-donors-be-safely
NEJM Journal Watch; Kaul D.

Sep 7th, 2021 - In selected SARS-CoV-2–infected nonlung donors, risk for donor-to-recipient transmission appears very low. In all deceased potential organ donors, upper respiratory tract specimens are tested for SARS-CoV-2. If lung transplantation is being con...

ISHLT consensus document on lung transplantation in patients with connective tissue dis...
https://doi.org/10.1016/j.healun.2021.07.013
The Journal of Heart and Lung Transplantation : the Offic... Crespo MM, Claridge T et. al.

Sep 4th, 2021 - Patients with connective tissues disease (CTD) are often on immunomodulatory agents before lung transplantation (LTx). Till now, there's no consensus on the safety of using these agents perioperative and post-transplant. The International Society ...

Consensus document for the selection of lung transplant candidates: An update from the ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979471
The Journal of Heart and Lung Transplantation : the Offic... Leard LE, Holm AM et. al.

Aug 23rd, 2021 - Tens of thousands of patients with advanced lung diseases may be eligible to be considered as potential candidates for lung transplant around the world each year. The timing of referral, evaluation, determination of candidacy, and listing of candi...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  127 results

4DX Functional Lung Imaging in the Diagnosis of Chronic Lung Allograft Dysfunction After Lung Transplantation
https://clinicaltrials.gov/ct2/show/NCT04892719

May 4th, 2022 - This is a pilot study to determine the feasibility and utility of Novel Functional Lung Imaging and Ventilation (4DxV) Analysis software in measurement of lung ventilation abnormalities and diagnosis of CLAD after lung transplantation. 4DxV is a t...

Nintedanib in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome Grade 0p-1-2
https://clinicaltrials.gov/ct2/show/NCT03283007

May 3rd, 2022 - Introduction: Lung transplantation (TxP) is now a validated treatment of end-stage pulmonary diseases, but long-term graft and patient survival are still hampered by the development of chronic allograft dysfunction (CLAD) affecting > 50% of patien...

Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction
https://clinicaltrials.gov/ct2/show/NCT03359863

May 2nd, 2022 - Despite advances in lung transplantation, median survival remains only 55% at 5 years. The primary cause of death is chronic lung allograft dysfunction (CLAD), occurring in 43% of recipients at 5 years. Recently, it has been recognized that CLAD c...

A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation
https://clinicaltrials.gov/ct2/show/NCT01175655

Apr 26th, 2022 - The primary aim of this study is to establish the safety of infusions of Mesenchymal Stromal Cells (MSC) from related or unrelated Human Leukocyte Antigen (HLA) identical or HLA mismatched donors in the management of bronchiolitis obliterans syndr...

Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)
https://clinicaltrials.gov/ct2/show/NCT03909750

Mar 16th, 2022 - Pulmonary Disorders, including both COPD & Restrictive Lung Disease (RLD) are often treated by limiting exposure to poor air quality, but there is no cure at this time. Most commonly, the patients are treated upon exacerbations, usually with some ...

see more →

News  183 results

Cough-Specific QOL Linked to Poor Outcomes in ILD Patients
https://www.medscape.com/viewarticle/972378

Apr 19th, 2022 - Poor cough-specific quality of life (QOL) was independently associated with respiratory hospitalization, death, and lung transplantation in a large population of well-characterized patients with interstitial lung disease (ILD), new research shows....

Lung Transplant in Patient With Terminal Lung Cancer
https://www.medscape.com/viewarticle/970969

Mar 25th, 2022 - Surgeons at Northwestern Medicine in Chicago have successfully performed a double lung transplant on a patient with stage 4 lung cancer, the health system reports. Lung transplantation for lung cancer is rare, and this double lung transplant — the...

Surgery Remains Imperative in Biomarker-Driven NSCLC Era
https://www.onclive.com/view/surgery-remains-imperative-in-biomarkerdriven-nsclc-era

Mar 10th, 2022 - David Mason, MD Amid the ongoing explosion of immunotherapy and targeted agents in non—small cell lung cancer (NSCLC), surgery remains a key component of the armamentarium. Surgery may be less of an option for patients with metastatic disease, b...

Dr. Mason on Progress Made in Resectable Stage III Lung Cancer
https://www.onclive.com/view/dr-mason-on-progress-made-in-resectable-stage-iii-lung-cancer

Mar 10th, 2022 - David P. Mason, MD, chief of thoracic surgery and lung transplantation, Baylor Scott & White Health System, chief of lung transplantation, head of the Department of Thoracic Surgery, Baylor University Medical Center, discusses the progress that ha...

Dr. Mason on the Reliability of the PD-L1 Biomarker
https://www.onclive.com/view/dr-mason-on-the-reliability-of-the-pdl1-biomarker

Mar 10th, 2022 - David P. Mason, MD, chief, Thoracic Surgery and Lung Transplantation, Baylor Scott & White Center for Thoracic Surgery, discusses the reliability of the PD-L1 biomarker in non—small cell lung cancer (NSCLC) and its potential applications in surgic...

see more →

Patient Education  4 results see all →